Research & Literature

Disseminated Mycobacterium haemophilum skeletal disease in a patient with interferon-gamma deficiency.

Otome O, O'Reilly M, Lim L

Internal medicine journal 2015; (45(10)):1073-6 doi:10.1111/imj.12875.

Nontuberculous mycobacterial infection with concurrent IgG4-related lymphadenopathy.

Liu TT, Weng SW, Wang MC, Huang WT

APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2016; (124(3)):216-20 doi:10.1111/apm.12492.

Factors associated with acquired Anti IFN- γ autoantibody in patients with nontuberculous mycobacterial infection.

Phoompoung P, Ankasekwinai N, Pithukpakorn M, et al.

PloS one 2017; (12(4)):e0176342 doi:10.1371/journal.pone.0176342.

Rituximab Restores IFN-γ-STAT1 Function and Ameliorates Disseminated Mycobacterium avium Infection in a Patient with Anti-Interferon-γ Autoantibody.

Koizumi Y, Sakagami T, Nishiyama N, et al.

Journal of clinical immunology 2017; (37(7)):644-649 doi:10.1007/s10875-017-0425-3.

Skin Manifestations in Patients with Adult-onset Immunodeficiency due to Anti-interferon-gamma Autoantibody: A Relationship with Systemic Infections.

Jutivorakool K, Sittiwattanawong P, Kantikosum K, et al.

Acta dermato-venereologica 2018; (98(8)):742-747 doi:10.2340/00015555-2959.

Intravenous Cyclophosphamide Therapy for Anti-IFN-Gamma Autoantibody-Associated Mycobacterium abscessus Infection.

Chetchotisakd P, Anunnatsiri S, Nanagara R, et al.

Journal of immunology research 2018; (2018()):6473629 doi:10.1155/2018/6473629.

Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti-interferon-γ autoantibodies.

Angkasekwinai N, Suputtamongkol Y, Phoompoung P, et al.

PloS one 2019; (14(4)):e0215581 doi:10.1371/journal.pone.0215581.

Blockade Effects of Anti-Interferon- (IFN-) γ Autoantibodies on IFN-γ-Regulated Antimicrobial Immunity.

Krisnawati DI, Liu YC, Lee YJ, et al.

Journal of immunology research 2019; (2019()):1629258 doi:10.1155/2019/1629258.

Natural History and Evolution of Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome in Thailand and the United States.

Hong GH, Ortega-Villa AM, Hunsberger S, et al.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2020; (71(1)):53-62 doi:10.1093/cid/ciz786.

Neutralizing Activity of Anti-interferon-γ Autoantibodies in Adult-Onset Immunodeficiency Is Associated With Their Binding Domains.

Yasamut U, Thongkum W, Moonmuang S, et al.

Frontiers in immunology 2019; (10()):1905 doi:10.3389/fimmu.2019.01905.

A case report of Talaromyces marneffei Oro-pharyngo-laryngitis: a rare manifestation of Talaromycosis.

Wongkamhla T, Chongtrakool P, Jitmuang A

BMC infectious diseases 2019; (19(1)):1034 doi:10.1186/s12879-019-4650-7.

Anti-IFN-γ autoantibodies underlie disseminated Talaromyces marneffei infections.

Guo J, Ning XQ, Ding JY, et al.

The Journal of experimental medicine 2020; (217(12)) doi:10.1084/jem.20190502.

Simultaneous disseminated infections with intracellular pathogens: an intriguing case report of adult-onset immunodeficiency with anti-interferon-gamma autoantibodies.

Roerden M, Döffinger R, Barcenas-Morales G, et al.

BMC infectious diseases 2020; (20(1)):828 doi:10.1186/s12879-020-05553-y.

Recurrent disseminated Mycobacterium avium in a female patient from Thailand with anti-interferon-gamma autoantibodies: dilemma on treatment approach.

Zeitler K, Walter J, Khan F, Sriaroon C

BMJ case reports 2021; (14(1)) doi:10.1136/bcr-2020-237909.

Endobronchial Lesions from Disseminated Mycobacterium avium Infection in a Patient with Anti-interferon-gamma Autoantibodies.

Mochizuka Y, Kono M, Hirama R, et al.

Internal medicine (Tokyo, Japan) 2021; (60(20)):3267-3272 doi:10.2169/internalmedicine.6693-20.

Latticed Gold Nanoparticle Conjugation via Monomeric Streptavidin in Lateral Flow Assay for Detection of Autoantibody to Interferon-Gamma.

Thongkum W, Yasamut U, Chupradit K, et al.

Diagnostics (Basel, Switzerland) 2021; (11(6)) doi:10.3390/diagnostics11060987.

Clinical findings of Talaromyces marneffei infection among patients with anti-interferon-γ immunodeficiency: a prospective cohort study.

Chen ZM, Li ZT, Li SQ, et al.

BMC infectious diseases 2021; (21(1)):587 doi:10.1186/s12879-021-06255-9.

Treatment Dilemmas in Disseminated Nontuberculous Mycobacterial Infections With Interferon-gamma Autoantibodies.

King EM, Weaver VK, Kestler MH

Open forum infectious diseases 2021; (8(7)):ofab253 doi:10.1093/ofid/ofab253.

Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection.

Chen LF, Yang CD, Cheng XB

Frontiers in immunology 2021; (12()):788368 doi:10.3389/fimmu.2021.788368.

Determination of a distinguished interferon gamma epitope recognized by monoclonal antibody relating to autoantibody associated immunodeficiency.

Yasamut U, Wisitponchai T, Lee VS, et al.

Scientific reports 2022; (12(1)):7608 doi:10.1038/s41598-022-11774-9.

Anti-Interferon-γ Autoantibodies Impair T-Lymphocyte Responses in Patients with Talaromyces marneffei Infections.

Chen ZM, Yang XY, Li ZT, et al.

Infection and drug resistance 2022; (15()):3381-3393 doi:10.2147/IDR.S364388.

Development of intravascular large B-cell lymphoma during prophylactic antibiotic treatment for anti-interferon-gamma autoantibody syndrome: A case report.

Tanigaki T, Kimizuka Y, Maki Y, et al.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy 2022; (28(11)):1562-1566 doi:10.1016/j.jiac.2022.07.015.

Case report: Diagnosis of Talaromyces marneffei infection in an HIV-negative patient with septic shock and high-titer anti-interferon gamma autoantibodies by metagenomic next-generation sequencing.

Du R, Feng Y, Mao H

Frontiers in cellular and infection microbiology 2023; (13()):1163846 doi:10.3389/fcimb.2023.1163846.

Multiple refractory intracellular pathogen infections in a human immunodeficiency virus-negative patient with anti-interferon-γ autoantibodies: a case report.

Wang H, Lei R, Ji Y, et al.

BMC infectious diseases 2023; (23(1)):493 doi:10.1186/s12879-023-08404-8.

Disseminated tuberculosis, CMV viraemia & haemophagocytic-lymphohistiocystosis syndrome in an adult patient with anti- IFNγ autoantibodies - case report and brief review.

Butel-Simoes GI, Kiss C, Kong K, et al.

Clinical immunology communications 2023; (4()):55-59 doi:10.1016/j.clicom.2023.08.001.

Multiple intracellular pathogen infections with ocular pathologies associated with adult-onset immunodeficiency due to anti-interferon-γ autoantibodies: a case report.

Ning Y, Yu Q, Liang H, et al.

BMC infectious diseases 2024; (24(1)):78 doi:10.1186/s12879-024-09003-x.

Anti-interferon-gamma autoantibody and salmonellosis: Case report and literature review.

Towachiraporn S, Thongwitokomarn H, Salee P

IDCases 2024; (35()):e01926 doi:10.1016/j.idcr.2024.e01926.

Th1 cell immune response in Talaromyces marneffei infection with anti-interferon-γ autoantibody syndrome.

Qiu Y, Li Z-T, Zeng W, et al.

Microbiology spectrum 2024; (12(5)):e0364623 doi:10.1128/spectrum.03646-23.

Clinical and chest CT manifestations of Talaromycosis marneffei: a retrospective study comparing anti-IFN-γ autoantibodies-positive and HIV-positive cases.

Wu X, Zhong Y, Li Z, et al.

BMC infectious diseases 2024; (24(1)):1357 doi:10.1186/s12879-024-10255-w.

Clinical Characteristics Analysis of 30 Cases of Interferon-γ Autoantibody-Positive Patients with Concurrent Mycobacterial Infection: A 6-Year Retrospective Study.

Zhao CY, Song C, He HW, et al.

Infection and drug resistance 2025; (18()):1097-1110 doi:10.2147/IDR.S493956.

Concomitant autoimmunity and late cancers in adult-onset immunodeficiency due to neutralizing anti-IFN-γ autoantibodies.

Tsai WT, Cheng CY, Sun HY, et al.

Frontiers in immunology 2025; (16()):1526439 doi:10.3389/fimmu.2025.1526439.

Clinical features of talaromycosis in people living with HIV/AIDS (PWHA) and patients with anti-interferon-γ autoantibodies.

Krasaewes K, Patanadamrongchai N, Kaewpoowat Q, et al.

PLoS neglected tropical diseases 2025; (19(5)):e0012992 doi:10.1371/journal.pntd.0012992.

Anti-IFN-γ Autoantibody Syndrome Presenting with Disseminated Nontuberculous Mycobacteria Infections: A Case Series of Therapeutic Implications and Review of Literature.

Cheng B, Bajwa B, Choi S, et al.

Tropical medicine and infectious disease 2025; (10(7)) doi:10.3390/tropicalmed10070202.

Disseminated Mycobacterium kansasii disease complicating Talaromyces marneffei infection in patient with anti-IFN-γ autoantibodies: a case report.

Wei S, Meng D, Qin J, et al.

BMC infectious diseases 2025; (25(1)):1157 doi:10.1186/s12879-025-11535-9.

The impact of neutralizing anti-IFN-γ autoantibodies on GBP5 expression and monocyte dysfunction in adult-onset immunodeficiency.

Sornsuwan K, Juntit OA, Thongheang K, et al.

Immunobiology 2025; (230(6)):153134 doi:10.1016/j.imbio.2025.153134.

Disseminated Talaromyces marneffei infection mimicking tuberculosis in an HIV-negative adult with anti-IFN-γ autoantibodies: a case report.

Liu J, Wu J, Zhang W, et al.

BMC infectious diseases 2025; (26(1)):1 doi:10.1186/s12879-025-12264-9.

Clinical Cognition and Practice in Anti-Interferon-γ Autoantibody-Associated Immunodeficiency Syndrome.

Liang S, Huang X, Liang X, et al.

Journal of clinical immunology 2026; (46(1)).

Anti-interferon-γ autoantibody syndrome mimicking lymphoproliferative disorders: a case series.

Ren D, Wee LEI, Lee SSM, et al.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2026; (170()):108860 doi:10.1016/j.ijid.2026.108860.

Disseminated Mycobacterium kansasii infection with osseous involvement in anti-interferon-γ autoantibody-associated adult-onset immunodeficiency: a case report and literature review.

Wang J, Lin K, Zhong Y, et al.

Frontiers in immunology 2026; (17()):1841472 doi:10.3389/fimmu.2026.1841472.

Bilateral otomastoiditis caused by Cryptococcus neoformans, a rare manifestation in patient with adult-onset immunodeficiency due to anti-interferon-γ autoantibodies.

Tangkum P, Janphet O, Vanichanan J

Medical mycology case reports 2026; (53()):100808 doi:10.1016/j.mmcr.2026.100808.

Case Report: Reactive Osteitis Accompanied With Non-Tuberculous Mycobacterial Infection Associated With Anti-IFN-γ Autoantibodies.

Wu L, Lv X, Zhao H, Deng X

International journal of rheumatic diseases 2026; (29(7)):e70778 doi:10.1111/1756-185x.70778.